Home Total folate and 5-methyltetrahydrofolate in the cerebrospinal fluid of children: correlation and reference values
Article
Licensed
Unlicensed Requires Authentication

Total folate and 5-methyltetrahydrofolate in the cerebrospinal fluid of children: correlation and reference values

  • Tomoyuki Akiyama EMAIL logo , Hiroko Tada , Tsugumi Shiokawa , Katsuhiro Kobayashi and Harumi Yoshinaga
Published/Copyright: May 5, 2015

Abstract

Background: Cerebral folate deficiency (CFD) may be underdiagnosed, as it manifests with various non-specific neurological symptoms. The diagnosis of CFD requires a determination of 5-methyltetrahydrofolate (5MTHF) in the cerebrospinal fluid (CSF), which is available in a limited number of specialized laboratories. In clinical biochemistry laboratories, total folate (TF) determination in serum or plasma is routinely performed by automated analyzers. The aim of this study is to determine whether the automated assay of CSF TF is a helpful screening tool for CFD.

Methods: We analyzed CSF samples collected from 73 pediatric patients. We measured CSF TF, serum TF, and CSF 5MTHF in 73, 70, and 48 patients, respectively. The assay of 5MTHF was conducted by a newly developed system utilizing liquid chromatography-tandem mass spectrometry (LC-MS/MS). We investigated the correlation between TF and 5MTHF in the CSF.

Results: There was a strong positive correlation between CSF TF and 5MTHF (ρ=0.930, p<0.0001, n=48). Age was negatively correlated with CSF TF (ρ=−0.557, p<0.0001, n=51), serum TF (ρ=−0.457, p=0.0008, n=51), and CSF 5MTHF (ρ=−0.387, p=0.0263, n=33), but not with the CSF/serum TF ratio.

Conclusions: The automated assay of CSF TF is helpful to estimate CSF 5MTHF. The CSF TF assay may have a significant impact on the early diagnosis of CFD, because clinicians have better access to it than the 5MTHF assay.


Corresponding author: Tomoyuki Akiyama, MD, PhD, Department of Child Neurology, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan, Phone: +81 86 2357372, Fax: +81 86 2357377, E-mail:

References

1. Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol 2004;46:843–51.Search in Google Scholar

2. Ramaekers VT, Rothenberg SP, Sequeira JM, Opladen T, Blau N, Quadros EV, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005;352:1985–91.10.1056/NEJMoa043160Search in Google Scholar

3. Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 2009;85:354–63.10.1016/j.ajhg.2009.08.005Search in Google Scholar

4. Garcia-Cazorla A, Quadros EV, Nascimento A, Garcia-Silva MT, Briones P, Montoya J, et al. Mitochondrial diseases associated with cerebral folate deficiency. Neurology 2008;70:1360–2.10.1212/01.wnl.0000309223.98616.e4Search in Google Scholar

5. Ramaekers VT, Hansen SI, Holm J, Opladen T, Senderek J, Häusler M, et al. Reduced folate transport to the CNS in female Rett patients. Neurology 2003;61:506–15.10.1212/01.WNL.0000078939.64774.1BSearch in Google Scholar

6. Blau N, Bonafé L, Krägeloh-Mann I, Thöny B, Kierat L, Häusler M, et al. Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: a new phenotype. Neurology 2003;61:642–7.10.1212/01.WNL.0000082726.08631.E7Search in Google Scholar

7. Ramaekers V, Sequeira JM, Quadros EV. Clinical recognition and aspects of the cerebral folate deficiency syndromes. Clin Chem Lab Med 2013;51:497–511.10.1515/cclm-2012-0543Search in Google Scholar

8. Surtees R, Hyland K. Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine, and 5-methyltetrahydrofolate in a reference population: cerebrospinal fluid S-adenosylmethionine declines with age in humans. Biochem Med Metab Biol 1990;44:192–9.10.1016/0885-4505(90)90060-ESearch in Google Scholar

9. Chládek J, Šišpera L, Martínková J. High-performance liquid chromatographic assay for the determination of 5-methyltetrahydrofolate in human plasma. J Chromatogr B 2000;744:307–13.10.1016/S0378-4347(00)00257-7Search in Google Scholar

10. Ormazabal A, García-Cazorla A, Pérez-Dueñas B, Gonzalez V, Fernández-Álvarez E, Pineda M, et al. Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: reference values for a paediatric population. Clin Chim Acta 2006;371:159–62.10.1016/j.cca.2006.03.004Search in Google Scholar PubMed

11. Verbeek MM, Blom AM, Wevers RA, Lagerwerf AJ, van de Geer J, Willemsen MA. Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations. Mol Genet Metab 2008;95:127–32.10.1016/j.ymgme.2008.07.004Search in Google Scholar PubMed

12. Opladen T, Ramaekers VT, Heimann G, Blau N. Analysis of 5-methyltetrahydrofolate in serum of healthy children. Mol Genet Metab 2006;87:61–5.10.1016/j.ymgme.2005.08.011Search in Google Scholar

13. Pfeiffer CM, Fazili Z, McCoy L, Zhang M, Gunter EW. Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. Clin Chem 2004;50:423–32.10.1373/clinchem.2003.026955Search in Google Scholar

14. Ormazábal A, Perez-Dueñas B, Sierra C, Urreitzi R, Montoya J, Serrano M, et al. Folate analysis for the differential diagnosis of profound cerebrospinal fluid folate deficiency. Clin Biochem 2011;44:719–21.10.1016/j.clinbiochem.2011.03.002Search in Google Scholar

15. Hansen FJ, Blau N. Cerebral folate deficiency: life-changing supplementation with folinic acid. Mol Genet Metab 2005;84:371–3.10.1016/j.ymgme.2004.12.001Search in Google Scholar

16. Greenblatt JM, Huffman LC, Reiss AL. Folic acid in neurodevelopment and child psychiatry. Prog Neuropsychopharmacol Biol Psychiatry 1994;18: 647–60.10.1016/0278-5846(94)90074-4Search in Google Scholar

Received: 2015-2-28
Accepted: 2015-3-31
Published Online: 2015-5-5
Published in Print: 2015-11-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Biomarkers of inflammatory bowel disease: ready for prime time?
  4. Review
  5. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis
  6. Mini Reviews
  7. Cell-free DNA for diagnosing myocardial infarction: not ready for prime time
  8. The Laboratory Medicine and the care of patients infected by the Ebola virus. Experience in a reference hospital of Madrid, Spain
  9. Opinion Papers
  10. Theranos phenomenon − part 2
  11. Considerations in parathyroid hormone testing
  12. Quantity quotient reporting. Comparison of various models
  13. Genetics and Molecular Diagnostics
  14. Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks
  15. Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience
  16. Non-invasive fetal ABO genotyping in maternal plasma using real-time PCR
  17. Screening non-deletion α-thalassaemia mutations in the HBA1 and HBA2 genes by high-resolution melting analysis
  18. General Clinical Chemistry and Laboratory Medicine
  19. European views on patients directly obtaining their laboratory test results
  20. Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients
  21. Thrombin generation, D-dimer and protein S in uncomplicated pregnancy
  22. Multi-analyte analysis of non-vitamin K antagonist oral anticoagulants in human plasma using tandem mass spectrometry
  23. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing
  24. Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease
  25. Reference Values and Biological Variations
  26. Total folate and 5-methyltetrahydrofolate in the cerebrospinal fluid of children: correlation and reference values
  27. Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV)
  28. Infectious Diseases
  29. Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype
  30. The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites
  31. Letter to the Editors
  32. Misleading high-sensitivity troponin algorithm for NSTEMI in the ESC guidelines
  33. Adjustment of serum potassium for age and platelet count. A simple step forward towards personalized medicine
  34. The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid
  35. Effect of storage time and temperature on the generation of reactive oxygen species in peripheral blood leukocytes
  36. Iohexol interference in the α2-globulin fraction of the serum protein capillary electrophoresis
  37. A functional variant in the γ-glutamyltransferase (GGT)1 gene is associated with airflow obstruction in smokers
  38. Comparison of measured venous carbon dioxide and calculated arterial bicarbonates according to the PaCO2 and PaO2 cut-off values of obesity hypoventilation syndrome
  39. Creatinine, Jaffe, and glucose: another inconvenient truth
  40. Analytical evaluation of a new liquid immunoturbidimetric assay for the determination of ferritin in serum
  41. Analytical assessment of the novel homocysteine liquid enzymatic assay on Beckman Coulter AU5800
  42. Immunoglobulin IgA, IgD, IgG, IgM and IgG subclass reference values in adults
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0208/html
Scroll to top button